Disease: Idiopathic thrombocytopenic purpura
- <em>FOXO1</em> Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia
- A case of alopecia areata multiplex accompanied by chronic idiopathic thrombocytopenic purpura
- A Case of Intravenous IVIg Interfering with Serological Test Results of HBV
- A case of TAFRO syndrome after vaccination, successfully treated with cyclosporine
- A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
- Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia in a Patient with Seronegative Arthritis: A Case Report
- ACVIM consensus statement on the diagnosis of immune thrombocytopenia in dogs and cats
- ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats
- Alternative Dosing of Eltrombopag for the Treatment of Chronic, Steroid-Refractory Immune Thrombocytopenia
- Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
- Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders
- Aplastic Anemia With Thrombosis Following the Administration of Immunosuppressant and Thrombopoietin Receptor Agonist (TPO-RA)
- Bevacizumab-induced immune thrombocytopenia in an ovarian cancer patient with mixed connective tissue disease: case report and literature review
- Broadening the horizon of immune thrombocytopenia through Omics approaches
- C-L Case Conference: Explicit, Implicit, and Tacit Consultation Questions for a Patient With Idiopathic Thrombocytopenic Purpura and Agitation
- Case report: Management of pregnancy-associated immune thrombocytopenia in a French bulldog with dystocia
- Cognitive impairment among patients with chronic immune thrombocytopenia
- Comprehensive analysis and prediction model of mitophagy and ferroptosis in primary immune thrombocytopenia
- Comprehensive analysis of the clinical manifestations and hematological parameters associated with secondary immune thrombocytopenia in patients with primary Sjögren syndrome: An observational study
- COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response
- COVID-19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence
- Cytokine expression in pediatric patients with immune thrombocytopenia (ITP) in different phases of disease
- Daucosterol regulates JAK2-STAT3 signaling pathway to promote megakaryocyte differentiation
- Description of therapeutic strategies in severe systemic lupus erythematosus-associated immune thrombocytopenia: a retrospective cohort study of response and relapse
- Detection and characterization of autoreactive memory stem T-cells in children with acute immune thrombocytopenia
- Diagnostic yield of bone marrow aspiration in paediatric primary immune thrombocytopenia: impact of evolution and adherence to medical guidelines over the last 25 years
- Differential alterations of CXCR3, CXCR5 and CX3CR1 in patients with immune thrombocytopenia
- Differential detection of megakaryocytic and erythroid DNA in plasma in hematological disorders
- Differential diagnosis and therapy of immune thrombocytopenia
- Effect of ADSCs on Th17/Treg and T-bet/GATA-3 in model mice with primary immune thrombocytopenia
- Efficacy and safety of eltrombopag in the treatment of primary immune thrombocytopenia: real-world data from a single medical center
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
- Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
- Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial
- Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial - Authors' reply
- Efgartigimod hilft bei Immunthrombozytopenie
- Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center
- Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome
- Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
- Fulminant Disseminated Coccidioidomycosis With Histoplasma Antigen Cross-Reactivity
- Genetic Predisposition to Vaccine-Induced Immune Thrombotic Thrombocytopenia: is there a Family Link?
- Gut microbiome composition and dysbiosis in immune thrombocytopenia: A review of literature
- Helicobacter pylori-Associated Immune Thrombocytopenia: Diagnostic and Therapeutic Approach
- Hemostatic mechanism of Jianpi Yiqi Shexue decoction in treatment of immune thrombocytopenia
- High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia
- Hyperbaric oxygen treatment in bilateral orchiopexy and post-circumcision haematoma in a thrombocytopenic patient with Noonan syndrome
- Hypermethylation of the FOXP3 gene regulates Tregs immunodysregulation in chronic idiopathic thrombocytopenic purpura
- Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia
- Idiopathic Thrombocytopenic Purpura (ITP) Complicated by a Hemorrhagic Ovarian Cyst and Hemoperitoneum: A Case Report
- Imaging‑based diagnosis of intrapancreatic accessory spleen: A case report
- Immune thrombocytopaenic purpura following COVID-19 infection masquerading as senile purpura
- Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management
- Immune thrombocytopenia guidelines get an annual checkup
- Immune Thrombocytopenia- Will it Stay or go Away?
- Immune Thrombocytopenic Purpura (ITP) and Chorioretinopathy in Chronic Granulomatous Disease: A Case Report
- Immune Thrombocytopenic Purpura Associated With Systemic Lupus Erythematosus, Helicobacter pylori, and Hepatitis B
- Impact of pre-delivery medication treatment on delivery outcome in patients with primary immune thrombocytopenia: a cohort study
- Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis
- Is it possible to predict morbidities in neonates born to mothers with immune thrombocytopenic purpura?: A retrospective cross-sectional study
- Left ventricular rupture due to myocardial infarction with nonobstructive coronary arteries in a patient with idiopathic thrombocytopenic purpura
- Mendelian randomization reveals association of gut microbiota with Henoch-Schonlein purpura and immune thrombocytopenia
- Navigating the conundrum of co-existing autoantibodies and alloantibodies in a case of Evans syndrome
- New findings and new methods on macrophages in primary immune thrombocytopenia
- Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies
- Pathophysiology and Diagnostics of Immune Thrombocytopenia
- Patient-centric care in primary immune thrombocytopenia (ITP): shared decision-making and assessment of health-related quality of life
- Pediatric Immune Thrombocytopenia
- Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome
- Perinatal outcomes in pregnant women with ITP: a single tertiary center experience
- Platelet TGF-β triggers immunosuppression in ITP
- Primary immune thrombocytopenia linked to the ingestion of guinea pigs (Cavia porcellus) causality or coincidence?
- Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia
- Rapid, Simple and Low-Cost Analytical Method Development for Quantification of Eltrombopag Olamine in Tablet Dosage by UV Spectroscopy Method
- Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus
- Real-world clinical outcomes with fostamatinib for the treatment of refractory chronic immune thrombocytopenia: a single-center experience
- Retrospective Evaluation of Survival and Prognostic Factors in Immune Thrombocytopenia: A Single-Center and Cross-Sectional Study
- Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis
- Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy
- Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes
- Romiplostim use in immune thrombocytopenia: Experience in Cuenca, Ecuador
- Safety and efficacy of danazol in immune thrombocytopenia: a systematic review
- Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study
- Sovleplenib in immune thrombocytopenia
- Successful use of eltrombopag in ITP post-splenectomy despite pre-splenectomy failure
- Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial
- The Decline of Open, Laparoscopic, and Robotic Splenectomies: A Single Center Experience
- The Differences of Serum Thrombopoietin Levels Between Acquired Aplastic Anemia and Immune Thrombocytopenia in Pediatric Patients
- The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China
- The first national pediatric immune thrombocytopenia registry in Iran: research protocol and preliminary study results
- The long-term efficacy of eltrombopag in children with immune thrombocytopenia
- The miR-641-STIM1 and SATB1 axes play important roles in the regulation of the Th17/Treg balance in ITP
- The role of CD83 in the pathogenesis of immune thrombocytopenia
- The role of platelet desialylation as a biomarker in primary immune thrombocytopenia: mechanisms and therapeutic perspectives
- The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia
- Thrombocytopenia following iron repletion with ferrous gluconate
- Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP
- Treatment outcomes and adherence to treatment in patients with immune thrombocytopenia in two Ethiopian teaching hospitals: a retrospective cohort study
- Trombocitopenia inmune primaria vinculada a la ingesta de cuy (Cavia porcellus)
- Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics
- Uso de romiplostim en trombocitopenia inmunitaria: experiencia en Cuenca (Ecuador)